NCAM1 and Cognitive impairment: This indicates again that plannexin's effect is independent of PSA-NCAM expression, and it underscores plannexin as an effective treatment for cognitive deficits associated with PSA-NCAM deficiency, a condition reported to accompany, for example, aging [44], [45].